Dr. Slanetz is the founder of the Company and has been President, Chief Executive Officer and a director of the Company full time since its inception. Prior to co-founding the Company, he served as Chief Executive Officer and President of Genetix Pharmaceuticals, Inc. Dr. Slanetz served as Vice President, Business Development of TRANSGENE in May. 1996. From 1994 to 1996, he served as Manager, New Product Planning and Development at Genentech Inc. Prior to that, Dr. Slanetz was a Management Consultant for Arthur D. Little. He received his Ph.D. in Molecular and Immunobiology from Yale University.
